Post-exposure prophylaxis (PEP) and pre-exposure prophylaxis (PrEP) at the Kitengela sub-county hospital, on February 27, 2024. [File, Standard]
Mary Auma chose love with open eyes. At just 19, she married a man living with HIV—armed not with denial, but with determination and daily doses of Pre-Exposure Prophylaxis (PrEP), the pill she believed would shield her from infection. But now, a year later, that shield is cracking.